On October 8, 2015 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, reported that the company will webcast presentations from its Research and Development (R&D) Day on Friday, October 16, 2015 starting at 9:00 a.m. ET in New York City (Press release, Agios Pharmaceuticals, OCT 8, 2015, View Source;p=RssLanding&cat=news&id=2095350 [SID:1234507668]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentations will include a review of Agios’ research approach and clinical development strategy for the company’s lead cancer metabolism and rare genetic metabolic disorders programs. Along with the Agios team, external speakers will review the reported clinical data from these programs and the diseases that these investigational medicines aim to treat, including acute myeloid leukemia, advanced solid tumors and pyruvate kinase deficiency.
Agios speakers scheduled to present include:
David Schenkein, M.D., Chief Executive Officer
Scott Biller, Ph.D., Chief Scientific Officer
Chris Bowden, M.D., Chief Medical Officer
Sam Agresta, M.D., Vice President, Head of Clinical Development
Ann Barbier, M.D., Ph.D., Vice President, Clinical Development, Rare Genetic Diseases
External speakers:
Timothy Cloughesy, M.D., Director, UCLA Neuro-Oncology Program and Professor, Ronald Reagan UCLA Medical Center
Courtney DiNardo, M.D., MSCE, Assistant Professor, Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
Agios invites the public and media to listen to the presentations via a live webcast that can be accessed under "Events & Presentations" in the Investors and Media section of the company’s website at agios.com. The presentations are scheduled to begin at approximately 9:00 a.m. ET. A replay of the webcast will be archived on the Agios website for approximately 30 days following the presentation.